FDA Approved: TYBOST — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Tybost (cobicistat) from Gilead Sciences, authorizing changes to its labeling related to HIV treatment regimens.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tybost (Cobicistat)

Snippet

SUPPL AP for TYBOST (COBICISTAT)